10 Best Mid Cap Pharma Stocks to Buy

2. Globus Medical Inc. (NYSE:GMED)

Market Capitalization as of July 22: $7.22 billion

Number of Hedge Fund Holders: 45

Globus Medical Inc. (NYSE:GMED) is one of the best mid cap pharma stocks to buy. On July 15, Globus Medical announced the introduction of DuraPro with Navigation. The next-gen oscillating system is designed to enhance procedural workflows through its safety features and efficiency, and is the latest addition to the company’s Power Portfolio.

DuraPro features cutting-edge oscillating technology that helps prevent soft tissue wrapping while maintaining a natural sensation similar to conventional spinning drills.

This system provides surgeons with instruments for efficient and accurate bone removal, while simultaneously utilizing its oscillating nature to safeguard delicate tissue.

Globus Medical Inc. (NYSE:GMED) is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the US and internationally.